Low-serum levels of IGFBP-2 are correlated with obesity [22], metabolic syndrome [18], and type 2 diabetes [48], whereas overexpression of IGFBP-2 protects against diabetes and obesity [22, 23]. Here, IGFBP2 is linked to diabetes mellitus.